-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, PNn9TEY6KFgPGPT4K+BD2/KV7gAUOuhcZUkYvI/SR1oEixndw8EDwEkx8USq0kme EsD0pN5Iaju/r+3/hemFWg== 0001209191-07-020266.txt : 20070328 0001209191-07-020266.hdr.sgml : 20070328 20070328165330 ACCESSION NUMBER: 0001209191-07-020266 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20070301 FILED AS OF DATE: 20070328 DATE AS OF CHANGE: 20070328 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LIPID SCIENCES INC/ CENTRAL INDEX KEY: 0000071478 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 430433090 STATE OF INCORPORATION: AZ FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 7068 KOLL CENTER PARKWAY STREET 2: SUITE 401 CITY: PLEASANTON STATE: CA ZIP: 94566 BUSINESS PHONE: 925-249-4000 MAIL ADDRESS: STREET 1: 7068 KOLL CENTER PARKWAY STREET 2: SUITE 401 CITY: PLEASANTON STATE: CA ZIP: 94566 FORMER COMPANY: FORMER CONFORMED NAME: NZ CORP DATE OF NAME CHANGE: 20000810 FORMER COMPANY: FORMER CONFORMED NAME: NEW MEXICO & ARIZONA LAND CO DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: RA Capital Biotech Fund II, L.P. CENTRAL INDEX KEY: 0001392402 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-00497 FILM NUMBER: 07724783 BUSINESS ADDRESS: STREET 1: 111 HUNTINGTON AVE, SUITE 610 CITY: BOSTON STATE: MA ZIP: 02199 BUSINESS PHONE: 617-778-2509 MAIL ADDRESS: STREET 1: 111 HUNTINGTON AVE, SUITE 610 CITY: BOSTON STATE: MA ZIP: 02199 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: RA Capital Biotech Fund LP CENTRAL INDEX KEY: 0001315082 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-00497 FILM NUMBER: 07724784 BUSINESS ADDRESS: STREET 1: 111 HUNTINGTON AVE CITY: BOSTON STATE: MA ZIP: 02199 MAIL ADDRESS: STREET 1: 111 HUNTINGTON AVE CITY: BOSTON STATE: MA ZIP: 02199 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kolchinsky Peter CENTRAL INDEX KEY: 0001384859 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-00497 FILM NUMBER: 07724785 BUSINESS ADDRESS: BUSINESS PHONE: 617-778-2512 MAIL ADDRESS: STREET 1: 111 HUNTINGTON AVE STREET 2: SUITE 610 CITY: BOSTON STATE: MA ZIP: 02199 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ALDRICH RICHARD CENTRAL INDEX KEY: 0001185039 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-00497 FILM NUMBER: 07724786 MAIL ADDRESS: STREET 1: 1365 MAIN STREET CITY: WALTHAM STATE: MA ZIP: 02451 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: RA CAPITAL MANAGEMENT, LLC CENTRAL INDEX KEY: 0001346824 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-00497 FILM NUMBER: 07724787 BUSINESS ADDRESS: STREET 1: 111 HUNTINGTON AVE, SUITE 610 CITY: BOSTON STATE: MA ZIP: 02199 BUSINESS PHONE: 617-778-2512 MAIL ADDRESS: STREET 1: 111 HUNTINGTON AVE, SUITE 610 CITY: BOSTON STATE: MA ZIP: 02199 3 1 doc3.xml FORM 3 SUBMISSION X0202 3 2007-03-01 0 0000071478 LIPID SCIENCES INC/ LIPD 0001346824 RA CAPITAL MANAGEMENT, LLC 111 HUNTINGTON AVENUE, SUITE 610 BOSTON MA 02199 0 0 1 0 0001185039 ALDRICH RICHARD C/O RA CAPITAL MANAGEMENT, LLC 111 HUNTINGTON AVENUE, SUITE 610 BOSTON MA 02199 0 0 1 0 0001384859 Kolchinsky Peter C/O RA CAPITAL MANAGEMENT, LLC 111 HUNTINGTON AVENUE, SUITE 610 BOSTON MA 02199 0 0 1 0 0001315082 RA Capital Biotech Fund LP 111 HUNTINGTON AVENUE, SUITE 610 BOSTON MA 02199 0 0 1 0 0001392402 RA Capital Biotech Fund II, L.P. 111 HUNTINGTON AVE, STE 610 BOSTON MA 02199 0 0 1 0 Common Stock 3713662 I See Footnote These shares represent 3,662,662 shares held by RA Capital Biotech Fund, L.P. ("Fund I"), and 51,000 shares held by RA Capital Biotech Fund II, L.P. ("Fund II"). RA Capital Management, LLC (the "General Partner") is the general partner of each of Fund I and Fund II, and Richard H. Aldrich and Peter Kolchinsky are the sole managers of RA Capital Management, LLC. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any. /s/ Peter Kolchinsky Manager of RA Capital Management, LLC 2007-03-27 /s/ Richard H. Aldrich 2007-03-27 /s/ Peter Kolchinsky 2007-03-27 /s/ Peter Kolchinsky Manager of RA Capital Management, LLC, General Partner of RA Capital Biotech Fund, L.P. 2007-03-27 /s/ Peter Kolchinsky Manager of RA Capital Management, LLC, General Partner of RA Capital Biotech Fund II, L.P. 2007-03-27 EX-24.3_180188 2 poa.txt POA DOCUMENT CONFIRMING STATEMENT This Statement confirms that the undersigned has authorized and designated Richard H. Aldrich, each acting singly, to execute and file on the undersigned's behalf all Forms 3, 4, and 5 (including any amendments thereto) that the undersigned may be required to file with the U.S. Securities and Exchange Commission as a result of the undersigned's ownership of or transactions in securities of Lipid Sciences, Inc. The authority of Richard H. Aldrich under this Statement shall continue until the undersigned is no longer required to file Forms 3, 4, and 5 with regard to the undersigned's ownership of or transactions in securities of Lipid Sciences, Inc. unless earlier revoked in writing. The undersigned acknowledges that Richard H. Aldrich are not assuming any of the undersigned's responsibilities to comply with Section 16 of the Securities Exchange Act of 1934. This Statement revokes the authority of any person named in any prior confirming statement relating to the undersigned's filing obligations with respect to securities of Lipid Sciences, Inc. who is not named herein, and this Statement replaces and supersedes any such prior confirming statement. Dated: March 27, 2007 /s/ Peter Kolchinsky Peter Kolchinsky CONFIRMING STATEMENT This Statement confirms that the undersigned has authorized and designated Peter Kolchinsky, each acting singly, to execute and file on the undersigned's behalf all Forms 3, 4, and 5 (including any amendments thereto) that the undersigned may be required to file with the U.S. Securities and Exchange Commission as a result of the undersigned's ownership of or transactions in securities of Lipid Sciences, Inc. The authority of Peter Kolchinsky under this Statement shall continue until the undersigned is no longer required to file Forms 3, 4, and 5 with regard to the undersigned's ownership of or transactions in securities of Lipid Sciences, Inc. unless earlier revoked in writing. The undersigned acknowledges that Peter Kolchinsky are not assuming any of the undersigned's responsibilities to comply with Section 16 of the Securities Exchange Act of 1934. This Statement revokes the authority of any person named in any prior confirming statement relating to the undersigned's filing obligations with respect to securities of Lipid Sciences, Inc. who is not named herein, and this Statement replaces and supersedes any such prior confirming statement. Dated: March 27, 2007 /s/ Richard H. Aldrich Richard H. Aldrich -----END PRIVACY-ENHANCED MESSAGE-----